Furthermore, concern about nonadherence to guidelines has increased, even though it has been well established that adherence is mandatory in order to prevent unnecessary testing that can cause harm to patients.
In summary, our evaluation provides key evidence on an important issue in clinical management: the fact that, while the efficacy of secondary prevention in CV disease is well established in patients adherent to medication, adherence is generally low, and this has a negative impact on clinical outcomes.
Patient-level factors predictive of medication adherence are well established and include age, sex, race/ethnicity, education, and income or socioeconomic status [ 8- 10].
The importance of maintaining high levels of ART adherence is well established [ 4, 5], and ensuring that vulnerable and disadvantaged populations have equal access to HIV treatment is crucial from both an individual and public health standpoint [ 3, 22].
Although the significant economic burden of UC and the low rate of adherence with UC medications has been well established in the literature, the impact of adherence with oral 5-ASA therapies on health care utilization and associated costs among patients with active UC has not been widely investigated.
Well established health benefits associated with greater adherence to a Mediterranean Diet pattern include: lower risks of "metabolic syndrome" (an important risk factor/precursor of diabetes and heart disease), reduced risks for type 2 diabetes, heart disease, certain cancers, and dementia; as well as greater longevity and well-being.
The association of clinical condition of children at initiation of ART and treatment adherence is not well established.
While there is no absolute consensus about the adherence of the kings before Darius, such as Cyrus and Cambyses, it is well established that Darius was an adherent of Zoroastrianism or at least a firm believer in Ahura Mazda.
The importance of this relationship and its influence on adherence to treatment is well established.
In a previous pilot study into medication non-adherence among haemodialysis patients at our institution, non-adherence rates were 33%% and several fold higher amongst New Zealand (NZ) Māori, Pacific Peoples and the elderly [ 9].> The consequences of medication non-adherence have not been well established in dialysis populations.
Oral TMZ formulations are well established and new oral formulations can encourage the adherence of patients to treatment.
